BD Names Pamela Spikner As Chief Accounting Officer And Controller

(MENAFN- PR Newswire)

"Pam has a proven track record of leadership in corporate finance and accounting, with a deep passion for building and
leading high-performing teams," said DelOrefice. "Her more than 25 years of expertise will play a pivotal role in the continued leadership of the finance organization at BD."

Spikner joins BD from R1 RCM, Inc., which provides technology-enabled revenue cycle management solutions to health care providers, where she served as chief accounting officer since July 2021. In that role, she oversaw financial reporting and compliance, led strategic financial planning, implemented operational efficiency programs, among other responsibilities. She previously held various accounting leadership roles during her 12-year tenure at Exelon Corporation, a Fortune 200 company and the nation's largest utility company, and served as assistant corporate controller from July 2019 through July 2021 at Hill-Rom Holdings, Inc., a medical device company. She began her career in the audit practice of PwC, where she worked with clients in the health care and insurance industries.

Pam holds a Bachelor of Science in Accounting from Indiana University of Pennsylvania. She is a certified public accountant (CPA) and a certified internal auditor (CIA).

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit
bd
or connect with us on LinkedIn at
, X (formerly Twitter)
@BDandCo
or Instagram
@becton_dickinson .

Contacts:
Media:	Investors:
Troy Kirkpatrick	Adam Reiffe
VP, Public Relations	Senior Director, Investor Relations
858.617.2361	201.847.6927
[email protected]	[email protected]

SOURCE BD (Becton, Dickinson and Company)

MENAFN10012025003732001241ID1109076293

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.